Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 375 entries
Sorted by: Best Match Show Resources per page
Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium.

Global cardiology science & practice

Duffey OJ, Smart N.
PMID: 28979901
Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201628. doi: 10.21542/gcsp.2016.28.

Survival rates following myocardial infarction have increased in recent years but current treatments for post-infarction recovery are inadequate and cannot induce regeneration of damaged hearts. Regenerative medicine could provide disease-reversing treatments by harnessing modern concepts in cell and developmental...

Cite
Duffey OJ, Smart N. Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium. Glob Cardiol Sci Pract. 2016;2016(4):e201628doi: 10.21542/gcsp.2016.28.
Duffey, O. J., & Smart, N. (2016). Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium. Global cardiology science & practice, 2016(4), e201628. https://doi.org/10.21542/gcsp.2016.28
Duffey, Owen J, and Smart, Nicola. "Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium." Global cardiology science & practice vol. 2016,4 (2016): e201628. doi: https://doi.org/10.21542/gcsp.2016.28
Duffey OJ, Smart N. Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium. Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201628. doi: 10.21542/gcsp.2016.28. PMID: 28979901; PMCID: PMC5624183.
Copy Download .nbib Format: NLM
CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?.

Global cardiology science & practice

Hassan M, Philip P.
PMID: 28979903
Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201634. doi: 10.21542/gcsp.2016.34.

Initial observational studies have identified high-density lipoprotein cholesterol (HDL-C) as an independent predictor of cardiovascular (CV) risk, even in patients on optimal statin therapy. However, the notion that higher HDL-C is better, has been seriously challenged by the results...

Cite
Hassan M, Philip P. CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?. Glob Cardiol Sci Pract. 2016;2016(4):e201634doi: 10.21542/gcsp.2016.34.
Hassan, M., & Philip, P. (2016). CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?. Global cardiology science & practice, 2016(4), e201634. https://doi.org/10.21542/gcsp.2016.34
Hassan, Mohamed, and Philip, Peter. "CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?." Global cardiology science & practice vol. 2016,4 (2016): e201634. doi: https://doi.org/10.21542/gcsp.2016.34
Hassan M, Philip P. CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?. Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201634. doi: 10.21542/gcsp.2016.34. PMID: 28979903; PMCID: PMC5624186.
Copy Download .nbib Format: NLM
Epicardial ablation of ventricular tachycardia in a patient with arrhythmogenic right ventricular dysplasia after failed conventional endocardial ablation: A case for remote navigation with functional image integration.

Global cardiology science & practice

Ernst S, Roy K, Lim E, Thomas G.
PMID: 28979908
Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201639. doi: 10.21542/gcsp.2016.39.

Arrhythmogenic right ventricular dysplasia (ARVD) is an inheritable heart muscle disease that predominantly affects the right ventricle (RV) and predisposes to ventricular arrhythmias and sudden cardiac death (SCD)

Cite
Ernst S, Roy K, Lim E, et al. Epicardial ablation of ventricular tachycardia in a patient with arrhythmogenic right ventricular dysplasia after failed conventional endocardial ablation: A case for remote navigation with functional image integration. Glob Cardiol Sci Pract. 2016;2016(4):e201639doi: 10.21542/gcsp.2016.39.
Ernst, S., Roy, K., Lim, E., & Thomas, G. (2016). Epicardial ablation of ventricular tachycardia in a patient with arrhythmogenic right ventricular dysplasia after failed conventional endocardial ablation: A case for remote navigation with functional image integration. Global cardiology science & practice, 2016(4), e201639. https://doi.org/10.21542/gcsp.2016.39
Ernst, Sabine, et al. "Epicardial ablation of ventricular tachycardia in a patient with arrhythmogenic right ventricular dysplasia after failed conventional endocardial ablation: A case for remote navigation with functional image integration." Global cardiology science & practice vol. 2016,4 (2016): e201639. doi: https://doi.org/10.21542/gcsp.2016.39
Ernst S, Roy K, Lim E, Thomas G. Epicardial ablation of ventricular tachycardia in a patient with arrhythmogenic right ventricular dysplasia after failed conventional endocardial ablation: A case for remote navigation with functional image integration. Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201639. doi: 10.21542/gcsp.2016.39. PMID: 28979908; PMCID: PMC5624191.
Copy Download .nbib Format: NLM
Addressing cardiovascular inequalities among indigenous Australians.

Global cardiology science & practice

Brown A.
PMID: 25610833
Glob Cardiol Sci Pract. 2012 Sep 10;2012(1):2. doi: 10.5339/gcsp.2012.2. eCollection 2012.

No abstract available.

Cite
Brown A. Addressing cardiovascular inequalities among indigenous Australians. Glob Cardiol Sci Pract. 2012;2012(1):2doi: 10.5339/gcsp.2012.2.
Brown, A. (2012). Addressing cardiovascular inequalities among indigenous Australians. Global cardiology science & practice, 2012(1), 2. https://doi.org/10.5339/gcsp.2012.2
Brown, Alex. "Addressing cardiovascular inequalities among indigenous Australians." Global cardiology science & practice vol. 2012,1 (2012): 2. doi: https://doi.org/10.5339/gcsp.2012.2
Brown A. Addressing cardiovascular inequalities among indigenous Australians. Glob Cardiol Sci Pract. 2012 Sep 10;2012(1):2. doi: 10.5339/gcsp.2012.2. eCollection 2012. PMID: 25610833; PMCID: PMC4239816.
Copy Download .nbib Format: NLM
Hypertrophic cardiomyopathy: The first century 1869-1969.

Global cardiology science & practice

Braunwald E.
PMID: 25610836
Glob Cardiol Sci Pract. 2012 Sep 06;2012(1):5. doi: 10.5339/gcsp.2012.5. eCollection 2012.

No abstract available.

Cite
Braunwald E. Hypertrophic cardiomyopathy: The first century 1869-1969. Glob Cardiol Sci Pract. 2012;2012(1):5doi: 10.5339/gcsp.2012.5.
Braunwald, E. (2012). Hypertrophic cardiomyopathy: The first century 1869-1969. Global cardiology science & practice, 2012(1), 5. https://doi.org/10.5339/gcsp.2012.5
Braunwald, Eugene. "Hypertrophic cardiomyopathy: The first century 1869-1969." Global cardiology science & practice vol. 2012,1 (2012): 5. doi: https://doi.org/10.5339/gcsp.2012.5
Braunwald E. Hypertrophic cardiomyopathy: The first century 1869-1969. Glob Cardiol Sci Pract. 2012 Sep 06;2012(1):5. doi: 10.5339/gcsp.2012.5. eCollection 2012. PMID: 25610836; PMCID: PMC4239819.
Copy Download .nbib Format: NLM
Molecular genetics made simple.

Global cardiology science & practice

Kassem HSh, Girolami F, Sanoudou D.
PMID: 25610837
Glob Cardiol Sci Pract. 2012 Jul 04;2012(1):6. doi: 10.5339/gcsp.2012.6. eCollection 2012.

Genetics have undoubtedly become an integral part of biomedical science and clinical practice, with important implications in deciphering disease pathogenesis and progression, identifying diagnostic and prognostic markers, as well as designing better targeted treatments. The exponential growth of our...

Cite
Kassem HSh, Girolami F, Sanoudou D. Molecular genetics made simple. Glob Cardiol Sci Pract. 2012;2012(1):6doi: 10.5339/gcsp.2012.6.
Kassem, H. S. h., Girolami, F., & Sanoudou, D. (2012). Molecular genetics made simple. Global cardiology science & practice, 2012(1), 6. https://doi.org/10.5339/gcsp.2012.6
Kassem, Heba Sh, et al. "Molecular genetics made simple." Global cardiology science & practice vol. 2012,1 (2012): 6. doi: https://doi.org/10.5339/gcsp.2012.6
Kassem HSh, Girolami F, Sanoudou D. Molecular genetics made simple. Glob Cardiol Sci Pract. 2012 Jul 04;2012(1):6. doi: 10.5339/gcsp.2012.6. eCollection 2012. PMID: 25610837; PMCID: PMC4239820.
Copy Download .nbib Format: NLM
Familial dilated cardiomyopathy: Current challenges and future directions.

Global cardiology science & practice

Fatkin D.
PMID: 25610839
Glob Cardiol Sci Pract. 2012 Aug 27;2012(1):8. doi: 10.5339/gcsp.2012.8. eCollection 2012.

No abstract available.

Cite
Fatkin D. Familial dilated cardiomyopathy: Current challenges and future directions. Glob Cardiol Sci Pract. 2012;2012(1):8doi: 10.5339/gcsp.2012.8.
Fatkin, D. (2012). Familial dilated cardiomyopathy: Current challenges and future directions. Global cardiology science & practice, 2012(1), 8. https://doi.org/10.5339/gcsp.2012.8
Fatkin, Diane. "Familial dilated cardiomyopathy: Current challenges and future directions." Global cardiology science & practice vol. 2012,1 (2012): 8. doi: https://doi.org/10.5339/gcsp.2012.8
Fatkin D. Familial dilated cardiomyopathy: Current challenges and future directions. Glob Cardiol Sci Pract. 2012 Aug 27;2012(1):8. doi: 10.5339/gcsp.2012.8. eCollection 2012. PMID: 25610839; PMCID: PMC4239822.
Copy Download .nbib Format: NLM
HPS2-THRIVE, AIM-HIGH and dal-OUTCOMES: HDL-cholesterol under attack.

Global cardiology science & practice

Hassan M.
PMID: 25763374
Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):235-40. doi: 10.5339/gcsp.2014.37. eCollection 2014.

No abstract available.

Cite
Hassan M. HPS2-THRIVE, AIM-HIGH and dal-OUTCOMES: HDL-cholesterol under attack. Glob Cardiol Sci Pract. 2014;2014(3):235-40doi: 10.5339/gcsp.2014.37.
Hassan, M. (2014). HPS2-THRIVE, AIM-HIGH and dal-OUTCOMES: HDL-cholesterol under attack. Global cardiology science & practice, 2014(3), 235-40. https://doi.org/10.5339/gcsp.2014.37
Hassan, Mohamed. "HPS2-THRIVE, AIM-HIGH and dal-OUTCOMES: HDL-cholesterol under attack." Global cardiology science & practice vol. 2014,3 (2014): 235-40. doi: https://doi.org/10.5339/gcsp.2014.37
Hassan M. HPS2-THRIVE, AIM-HIGH and dal-OUTCOMES: HDL-cholesterol under attack. Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):235-40. doi: 10.5339/gcsp.2014.37. eCollection 2014. PMID: 25763374; PMCID: PMC4352676.
Copy Download .nbib Format: NLM
PARIS: A good start for exercise in HFPEF.

Global cardiology science & practice

Elamragy AA.
PMID: 25763377
Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):249-53. doi: 10.5339/gcsp.2014.40. eCollection 2014.

No abstract available.

Cite
Elamragy AA. PARIS: A good start for exercise in HFPEF. Glob Cardiol Sci Pract. 2014;2014(3):249-53doi: 10.5339/gcsp.2014.40.
Elamragy, A. A. (2014). PARIS: A good start for exercise in HFPEF. Global cardiology science & practice, 2014(3), 249-53. https://doi.org/10.5339/gcsp.2014.40
Elamragy, Ahmed A. "PARIS: A good start for exercise in HFPEF." Global cardiology science & practice vol. 2014,3 (2014): 249-53. doi: https://doi.org/10.5339/gcsp.2014.40
Elamragy AA. PARIS: A good start for exercise in HFPEF. Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):249-53. doi: 10.5339/gcsp.2014.40. eCollection 2014. PMID: 25763377; PMCID: PMC4352679.
Copy Download .nbib Format: NLM
Quantitative assessment of right ventricular structure and flow dynamics in pulmonary homograft obstruction.

Global cardiology science & practice

Chapron J, Aguib H, Theodoropoulos S, Kalantzi M, Yacoub M, Torii R.
PMID: 25763381
Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):350-3. doi: 10.5339/gcsp.2014.47. eCollection 2014.

No abstract available.

Cite
Chapron J, Aguib H, Theodoropoulos S, et al. Quantitative assessment of right ventricular structure and flow dynamics in pulmonary homograft obstruction. Glob Cardiol Sci Pract. 2014;2014(3):350-3doi: 10.5339/gcsp.2014.47.
Chapron, J., Aguib, H., Theodoropoulos, S., Kalantzi, M., Yacoub, M., & Torii, R. (2014). Quantitative assessment of right ventricular structure and flow dynamics in pulmonary homograft obstruction. Global cardiology science & practice, 2014(3), 350-3. https://doi.org/10.5339/gcsp.2014.47
Chapron, Julien, et al. "Quantitative assessment of right ventricular structure and flow dynamics in pulmonary homograft obstruction." Global cardiology science & practice vol. 2014,3 (2014): 350-3. doi: https://doi.org/10.5339/gcsp.2014.47
Chapron J, Aguib H, Theodoropoulos S, Kalantzi M, Yacoub M, Torii R. Quantitative assessment of right ventricular structure and flow dynamics in pulmonary homograft obstruction. Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):350-3. doi: 10.5339/gcsp.2014.47. eCollection 2014. PMID: 25763381; PMCID: PMC4352686.
Copy Download .nbib Format: NLM
Reprogramming for cardiac regeneration.

Global cardiology science & practice

Raynaud CM, Ahmad FS, Allouba M, Abou-Saleh H, Lui KO, Yacoub M.
PMID: 25763379
Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):309-29. doi: 10.5339/gcsp.2014.44. eCollection 2014.

Treatment of cardiovascular diseases remains challenging considering the limited regeneration capacity of the heart muscle. Developments of reprogramming strategies to create in vitro and in vivo cardiomyocytes have been the focus point of a considerable amount of research in...

Cite
Raynaud CM, Ahmad FS, Allouba M, et al. Reprogramming for cardiac regeneration. Glob Cardiol Sci Pract. 2014;2014(3):309-29doi: 10.5339/gcsp.2014.44.
Raynaud, C. M., Ahmad, F. S., Allouba, M., Abou-Saleh, H., Lui, K. O., & Yacoub, M. (2014). Reprogramming for cardiac regeneration. Global cardiology science & practice, 2014(3), 309-29. https://doi.org/10.5339/gcsp.2014.44
Raynaud, Christophe Michel, et al. "Reprogramming for cardiac regeneration." Global cardiology science & practice vol. 2014,3 (2014): 309-29. doi: https://doi.org/10.5339/gcsp.2014.44
Raynaud CM, Ahmad FS, Allouba M, Abou-Saleh H, Lui KO, Yacoub M. Reprogramming for cardiac regeneration. Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):309-29. doi: 10.5339/gcsp.2014.44. eCollection 2014. PMID: 25763379; PMCID: PMC4352683.
Copy Download .nbib Format: NLM
The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension.

Global cardiology science & practice

Ormiston ML, Upton PD, Li W, Morrell NW.
PMID: 26779522
Glob Cardiol Sci Pract. 2015 Nov 17;2015(4):47. doi: 10.5339/gcsp.2015.47. eCollection 2015.

Human genetic discoveries offer a powerful method to implicate pathways of major importance to disease pathobiology and hence provide targets for pharmacological intervention. The genetics of pulmonary arterial hypertension (PAH) strongly implicates loss-of-function of the bone morphogenetic protein type...

Cite
Ormiston ML, Upton PD, Li W, et al. The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension. Glob Cardiol Sci Pract. 2015;2015(4):47doi: 10.5339/gcsp.2015.47.
Ormiston, M. L., Upton, P. D., Li, W., & Morrell, N. W. (2015). The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension. Global cardiology science & practice, 2015(4), 47. https://doi.org/10.5339/gcsp.2015.47
Ormiston, Mark L, et al. "The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension." Global cardiology science & practice vol. 2015,4 (2015): 47. doi: https://doi.org/10.5339/gcsp.2015.47
Ormiston ML, Upton PD, Li W, Morrell NW. The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension. Glob Cardiol Sci Pract. 2015 Nov 17;2015(4):47. doi: 10.5339/gcsp.2015.47. eCollection 2015. PMID: 26779522; PMCID: PMC4710869.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 375 entries